Accuray Incorporated to Host Investor Meeting at ASTRO 2011

August 25, 2011 at 7:41 PM EDT

SUNNYVALE, Calif., Aug. 25, 2011 /PRNewswire via COMTEX/ --

Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 3, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami Beach, Florida. The meeting is open to institutional investors and research analysts.

Accuray's management will host a breakfast meeting, beginning at 7:00 a.m. E.D.T. on Monday, October 3 at the W Hotel, 2201 Collins Avenue, Miami Beach, in the Great Room on the lobby floor. Presentations will provide updates on corporate developments, a review of Accuray's newest technologies and an overview of the latest clinical data.

Attendees are asked to register no later than Friday, September 30 from our event website: http://www.cvent.com/d/9cq714.

A live webcast of the presentation will be available online from the investor relations section of the company's website. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray's innovative technologies - the CyberKnife System and TomoTherapy Systems - set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Euan Thomson, Ph.D.
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869

SOURCE Accuray Incorporated